MTOR and neoplasm: Treatment with inhibitors of the PI3K/mTOR pathway significantly reduced tumor growth rates, whereas an inhibitor of the proteasome showed only modest effect depending on tumor size, and inhibitors of histone deacetylases and DNA topoisomerase produced no tumor response in this model.